BEAM

Beam Therapeutics Inc

NASDAQ · Biotechnology

$26.52

+1.79 (+7.24%)

Mid-Cap Stocks Biotech Stocks Healthcare Stocks

Analyst Consensus

Strong Buy

23 analysts

Buy 20 87%

Hold 3 13%

Sell 0 0%

Price Target

Analyst Price Target +134.0% upside

Low Target $37.88

Average Target $62.07

High Target $80.69

Current Price $26.52

Current
$26.52

Target
$62.07

$37.88 $62.07 avg $80.69